Last reviewed · How we verify

NCT06256276

Nutritional Therapy for Autonomic Dysfunction in Elderly Heart Failure Patients

Completed NA Last updated 13 February 2024
What this trial tests

NA trial testing Whey protein powder and L-carnitine in Heart Failure in 21 participants. Completed in 1 February 2018.

Timeline
26 July 2016
Primary endpoint
11 January 2018
1 February 2018

Quick facts

Lead sponsorUniversity of Arkansas
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment21
Start date26 July 2016
Primary completion11 January 2018
Estimated completion1 February 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Arkansas

Who can join

Adults 60 to 90, female only, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent studies suggest that patients with heart failure (HF) may have a reduced ability to control the tone of their blood vessels, heart rate or blood pressure in response to stress. This study will test whether 16 weeks of protein supplements can improve control of blood pressure and heart rate in HF patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Protein Supplementation on Orthostatic Hypotension in Older Adult Patients with Heart Failure.
    Azhar G, Pangle AK, Coker K, Sharma S, et al · · 2025 · PMID 40126292 · DOI 10.3390/geriatrics10020042

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other University of Arkansas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06256276.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing